The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation

by Alicja Góralczyk, Katarzyna Kolossa, Marzena Waszczak-Jeka, Rafał Adamczak, Sławomir Jeka
Published 2020-07-01

Assessment of the usefulness of skin autofluorescence as an indicator of disease activity and of the risk of developing diabetes in patients suffering from rheumatoid arthritis

by Paweł Żuchowski, Katarzyna Kolossa, Sławomir Jeka, Rafał Wojciechowski, Arnika Wilińska-Jankowska, Marzena Waszczak
Published 2015-12-01

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis

by Milena Iwaszko, Jerzy Świerkot, Katarzyna Kolossa, Sławomir Jeka, Piotr Wiland, Katarzyna Bogunia-Kubik
Published 2018-01-01

Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64

by Milena Iwaszko, Jerzy Świerkot, Katarzyna Kolossa, Sławomir Jeka, Piotr Wiland, Katarzyna Bogunia-Kubik
Published 2018-02-01

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis P...

by Milena Iwaszko, Joanna Wielińska, Jerzy Świerkot, Katarzyna Kolossa, Renata Sokolik, Bartosz Bugaj, Monika Chaszczewska-Markowska, Sławomir Jeka, Sławomir Jeka, Katarzyna Bogunia-Kubik
Published 2021-06-01